Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

CATALYST PHARMACEUTICALS INC (CPRX)

358 + Investors. Track Smart Money conviction in CPRX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
1Q ▲
Buyers last Q
51%

Smart Money Signals — CPRX

Based on 354 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added CPRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
354 hedge funds hold CPRX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +12% more funds vs a year ago

fund count last 6Q
+37 new funds entered over the past year (+12% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 51% buying

184 buying175 selling
Last quarter: 184 funds bought or added vs 175 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new CPRX position: 70 → 45 → 50 → 68. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

53% of holders stayed for 2+ years

■ 53% conviction (2yr+) ■ 25% medium ■ 22% new
187 out of 354 hedge funds have held CPRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +19% but shares only +1% — price-driven

Value
+19%
Shares
+0%
Last quarter: the total dollar value of institutional holdings rose +19%, but actual share count only changed +1%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~68 new funds/quarter

54 → 70 → 45 → 50 → 68 new funds/Q
New funds entering each quarter: 70 → 45 → 50 → 68. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 59% of holders stayed 2+ years

■ 59% veterans ■ 11% 1-2yr ■ 30% new
Of 358 current holders: 211 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds
43 of 354 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in CPRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CPRX

In 2025 Q4, 184 hedge funds were net buyers of CPRX (68 opened a new position, 116 added to an existing one), while 175 reduced or exited (123 trimmed, 52 sold completely) — a 51% buyer ratio, indicating a slight buying edge. 44% of total institutional value in CPRX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 354.

Hedge Fund Ownership: CPRX

How many hedge funds hold CPRX — quarterly history vs. share price
Quarterly hedge fund ownership of CPRX vs. share price

Market Analysis: CPRX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CPRX

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 3 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
3.2
/ 10
conviction
Hedge Fund Positioning: CPRX
2026 Q1 Stats Unlock in 8 days 358 + Investors

Track Smart Money conviction in CPRX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 358 345 3.77%
13F Shares 103M 102M 0.71%
Total Value $2.38B $1.99B 19.11%
New Positions 68 50 +18
Increased Positions 122 125 -3
Closed Positions 52 53 -1
Reduced Positions 133 135 -2
Total Calls 2 3 -33.33%
Total Puts 2 4 -50.0%
PUT/CALL Ratio 1.0 1.33 Neutral

Statistics: CPRX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

358 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CPRX. Verified SEC 13F-HR filings.

Top 25 institutional holders of CPRX — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 GABLES CAPITAL MANAGEMENT INC. 4.45% 424,581 $10.5M
2 JW Asset Management, LLC 3.95% 388,392 $9.6M
3 Sidoxia Capital Management, LLC 1.52% 71,316 $1.8M
4 Advisors Preferred, LLC 1.39% 381,183 $9.4M
5 Future Fund LLC 0.82% 94,727 $2.3M
6 CLARK ESTATES INC/NY 0.68% 113,918 $2.8M
7 Zinnia Wealth Advisory, LLC 0.61% 22,147 $548K
8 JUNCTURE WEALTH STRATEGIES, LLC 0.59% 71,809 $1.8M
9 AlphaCentric Advisors LLC 0.58% 23,286 $577K
10 Jackson Creek Investment Advisors LLC 0.56% 77,304 $2K
11 Stanley-Laman Group, Ltd. 0.47% 155,021 $3.8M
12 HUSSMAN STRATEGIC ADVISORS, INC. 0.45% 84,000 $2.1M
13 Linden Thomas Advisory Services, LLC 0.39% 163,591 $4.1M
14 CHASE INVESTMENT COUNSEL CORP 0.39% 60,000 $1.5M
15 Oliver Luxxe Assets LLC 0.36% 96,636 $2.4M
16 City Center Advisors, LLC 0.31% 13,664 $338K
17 Convergence Investment Partners, LLC 0.31% 75,682 $1.9M
18 FULCRUM WEALTH ADVISORS, LLC 0.22% 10,938 $271K
19 CAMPBELL NEWMAN ASSET MANAGEMENT INC 0.19% 92,476 $2.3M
20 AlphaQuest LLC 0.17% 130,106 $3.0M
21 Cyndeo Wealth Partners, LLC 0.15% 118,444 $2.9M
22 Covestor Ltd 0.14% 8,219 —
23 Brookwood Investment Group LLC 0.14% 44,800 $1.1M
24 Moran Wealth Management, LLC 0.13% 168,961 $4.2M
25 RETIREMENT GUYS FORMULA LLC 0.11% 9,626 $238K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — CATALYST PHARMACEUTICALS INC (CPRX)

What does the Smart Money Trend signal show for CPRX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added CPRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CPRX?

Slight buying edge — 51% buying: Last quarter: 184 funds bought or added vs 175 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CPRX holders?

Elite ownership — 44% AUM from top-100 funds: 43 of 354 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in CPRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CPRX?

53% of holders stayed for 2+ years: 187 out of 354 hedge funds have held CPRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.